BS EN ISO 11608-3:2022 – TC
$217.84
Tracked Changes. Needle-based injection systems for medical use. Requirements and test methods – Containers and integrated fluid paths
Published By | Publication Date | Number of Pages |
BSI | 2022 | 92 |
This document specifies requirements and test methods for design verification of containers and integrated fluid paths used with Needle-Based Injection Systems (NISs) according to ISO 11608-1. It is applicable to single and multi-dose containers either filled by the manufacturer (primary container closure) or by the end-user (reservoir) (e.g. cartridges, syringes) and fluid paths that are integrated with the NIS at the point of manufacture. This document is also applicable to prefilled syringes (see ISO 11040-8) when used with a NIS (see also scope of ISO 11608-1:2022). This document is not applicable to the following products: — sterile hypodermic needles; — sterile hypodermic syringes; — sterile single-use syringes, with or without needle, for insulin; — containers that can be refilled multiple times; — containers intended for dental use; — catheters or infusion sets that are attached or assembled separately by the user.
PDF Catalog
PDF Pages | PDF Title |
---|---|
54 | undefined |
57 | European foreword Endorsement notice |
61 | Foreword |
62 | Introduction |
64 | 1 Scope 2 Normative references |
65 | 3 Terms and definitions |
66 | 4 Requirements 4.1 General |
67 | 4.2 Container integrity 4.2.1 Container Closure Integrity (CCI) 4.2.2 Resealability — All multi-dose cartridges or reservoirs with discs 4.2.3 Fragmentation (disc coring) – cartridges or reservoirs with discs |
68 | 4.3 Cannula requirements (as part of the fluid path) 4.3.1 Rigid needles 4.3.2 Soft cannulas 4.4 Fluid line connections 4.5 Medicinal product compatibility 4.5.1 General |
69 | 4.5.2 Medicinal product compatibility with reservoir and integrated fluid path materials 4.5.3 Reservoir and integrated fluid path particulate matter 4.5.4 Reservoir and fluid path pyrogenicity |
70 | 4.5.5 Reservoir and integrated fluid path leachables 4.5.6 Sterilization of the reservoir and/or integrated fluid path |
71 | 4.6 Medicinal product leakage 5 Test methods 5.1 Resealability for multi-dose cartridges or reservoirs |
72 | 5.2 Fragmentation (disc coring) – cartridges or reservoirs |
73 | 5.3 Sub-visible particulates 5.4 Visible particulates 6 Information supplied with the container 6.1 General 6.2 Marking on the unit packaging |
74 | Annex A (informative) Medicinal product compatibility references – Requirements, guidance, standards or compendia material |
77 | Annex B (informative) Historical references to previous editions |
80 | Annex C (informative) Theoretical support for resealability requirements |
83 | Annex D (informative) Reservoir and integrated fluid path leachables |
85 | Annex E (informative) Medicinal product compatibility |
87 | Annex F (informative) Primary container closure as compared to reservoir and fluid path |
90 | Bibliography |